The West of England Genomic Medicine Centre (WEGMC) is one of a network of 13 regional Genomic Medicine Centres in England that have been set up within the NHS to help gain a better understanding of the genetic causes of cancer and rare disease.
The GMC network is part of the Government’s 100,000 Genomes Project, which aims to analyse 100,000 genomes from patients with cancer and rare diseases. The project also aims to transform on-going care by implementing genomic medicine into the NHS. This will enable more accurate diagnosis of disease and develop novel treatments in the future that offer long-term benefit to NHS patients.
In order to meets these aims, the WEGMC has established collaborations with partner organisations within region, including five NHS Provider Trusts led by University Hospitals Bristol, three Universities, seven Clinical Commissioning Groups, Health Education South West, NHS England South West, Avon and Wiltshire Mental Health Partnership NHS Trust, West of England Clinical Research Network and the West of England AHSN. The WEGMC works closely with NHS England and Genomics England to ensure national standardisation of enrolment practice and transformation programmes.